CZ233599A3 - Inhibitory farnesyltransferázy, způsob jejich přípravy a farmaceutické prostředky, které je obsahují - Google Patents

Inhibitory farnesyltransferázy, způsob jejich přípravy a farmaceutické prostředky, které je obsahují Download PDF

Info

Publication number
CZ233599A3
CZ233599A3 CZ992335A CZ233599A CZ233599A3 CZ 233599 A3 CZ233599 A3 CZ 233599A3 CZ 992335 A CZ992335 A CZ 992335A CZ 233599 A CZ233599 A CZ 233599A CZ 233599 A3 CZ233599 A3 CZ 233599A3
Authority
CZ
Czechia
Prior art keywords
group
methoxyphenyl
isoindole
ethano
benzo
Prior art date
Application number
CZ992335A
Other languages
Czech (cs)
English (en)
Inventor
Jean-Dominique Bourzat
Alain Commercon
Norbert Dereu
Patrick Mailliet
Fabienne Sounigo-Thompson
Jean-Paul Martin
Marc Capet
Michel Cheve
Original Assignee
Rhone-Poulenc Rorer S. A.
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Rhone-Poulenc Rorer S. A. filed Critical Rhone-Poulenc Rorer S. A.
Publication of CZ233599A3 publication Critical patent/CZ233599A3/cs

Links

Classifications

    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D401/00Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom
    • C07D401/02Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom containing two hetero rings
    • C07D401/12Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom containing two hetero rings linked by a chain containing hetero atoms as chain links
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P35/00Antineoplastic agents
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P35/00Antineoplastic agents
    • A61P35/02Antineoplastic agents specific for leukemia
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P43/00Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D209/00Heterocyclic compounds containing five-membered rings, condensed with other rings, with one nitrogen atom as the only ring hetero atom
    • C07D209/56Ring systems containing three or more rings
    • C07D209/58[b]- or [c]-condensed
    • C07D209/724,7-Endo-alkylene-iso-indoles
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D403/00Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, not provided for by group C07D401/00
    • C07D403/02Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, not provided for by group C07D401/00 containing two hetero rings
    • C07D403/04Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, not provided for by group C07D401/00 containing two hetero rings directly linked by a ring-member-to-ring-member bond
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D405/00Heterocyclic compounds containing both one or more hetero rings having oxygen atoms as the only ring hetero atoms, and one or more rings having nitrogen as the only ring hetero atom
    • C07D405/02Heterocyclic compounds containing both one or more hetero rings having oxygen atoms as the only ring hetero atoms, and one or more rings having nitrogen as the only ring hetero atom containing two hetero rings
    • C07D405/04Heterocyclic compounds containing both one or more hetero rings having oxygen atoms as the only ring hetero atoms, and one or more rings having nitrogen as the only ring hetero atom containing two hetero rings directly linked by a ring-member-to-ring-member bond
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D405/00Heterocyclic compounds containing both one or more hetero rings having oxygen atoms as the only ring hetero atoms, and one or more rings having nitrogen as the only ring hetero atom
    • C07D405/14Heterocyclic compounds containing both one or more hetero rings having oxygen atoms as the only ring hetero atoms, and one or more rings having nitrogen as the only ring hetero atom containing three or more hetero rings
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D409/00Heterocyclic compounds containing two or more hetero rings, at least one ring having sulfur atoms as the only ring hetero atoms
    • C07D409/02Heterocyclic compounds containing two or more hetero rings, at least one ring having sulfur atoms as the only ring hetero atoms containing two hetero rings
    • C07D409/04Heterocyclic compounds containing two or more hetero rings, at least one ring having sulfur atoms as the only ring hetero atoms containing two hetero rings directly linked by a ring-member-to-ring-member bond
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D409/00Heterocyclic compounds containing two or more hetero rings, at least one ring having sulfur atoms as the only ring hetero atoms
    • C07D409/02Heterocyclic compounds containing two or more hetero rings, at least one ring having sulfur atoms as the only ring hetero atoms containing two hetero rings
    • C07D409/12Heterocyclic compounds containing two or more hetero rings, at least one ring having sulfur atoms as the only ring hetero atoms containing two hetero rings linked by a chain containing hetero atoms as chain links
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D409/00Heterocyclic compounds containing two or more hetero rings, at least one ring having sulfur atoms as the only ring hetero atoms
    • C07D409/14Heterocyclic compounds containing two or more hetero rings, at least one ring having sulfur atoms as the only ring hetero atoms containing three or more hetero rings

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Health & Medical Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • Veterinary Medicine (AREA)
  • General Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Public Health (AREA)
  • Hematology (AREA)
  • Oncology (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Indole Compounds (AREA)
  • Plural Heterocyclic Compounds (AREA)
  • Heterocyclic Carbon Compounds Containing A Hetero Ring Having Oxygen Or Sulfur (AREA)
  • Epoxy Compounds (AREA)
  • Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
CZ992335A 1996-12-30 1997-12-23 Inhibitory farnesyltransferázy, způsob jejich přípravy a farmaceutické prostředky, které je obsahují CZ233599A3 (cs)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
FR9616206A FR2757855B1 (fr) 1996-12-30 1996-12-30 Nouveaux inhibiteurs de farnesyl transferase, leur preparation et les compositions pharmaceutiques qui les contiennent

Publications (1)

Publication Number Publication Date
CZ233599A3 true CZ233599A3 (cs) 1999-09-15

Family

ID=9499293

Family Applications (1)

Application Number Title Priority Date Filing Date
CZ992335A CZ233599A3 (cs) 1996-12-30 1997-12-23 Inhibitory farnesyltransferázy, způsob jejich přípravy a farmaceutické prostředky, které je obsahují

Country Status (32)

Country Link
EP (1) EP0948483B1 (forum.php)
JP (1) JP2001509147A (forum.php)
KR (1) KR20000062391A (forum.php)
AR (1) AR008950A1 (forum.php)
AT (1) ATE214367T1 (forum.php)
AU (1) AU741921B2 (forum.php)
BR (1) BR9714498A (forum.php)
CA (1) CA2275943A1 (forum.php)
CO (1) CO4920252A1 (forum.php)
CZ (1) CZ233599A3 (forum.php)
DE (1) DE69711081T2 (forum.php)
DK (1) DK0948483T3 (forum.php)
DZ (1) DZ2389A1 (forum.php)
EA (1) EA002114B1 (forum.php)
ES (1) ES2172033T3 (forum.php)
FR (1) FR2757855B1 (forum.php)
HU (1) HUP0001747A3 (forum.php)
ID (1) ID22922A (forum.php)
IL (1) IL130453A0 (forum.php)
MA (1) MA26460A1 (forum.php)
NO (1) NO993225L (forum.php)
NZ (1) NZ336042A (forum.php)
PE (1) PE28199A1 (forum.php)
PL (1) PL334345A1 (forum.php)
PT (1) PT948483E (forum.php)
SK (1) SK88399A3 (forum.php)
TN (1) TNSN97214A1 (forum.php)
TR (1) TR199901502T2 (forum.php)
UY (1) UY24832A1 (forum.php)
WO (1) WO1998029390A1 (forum.php)
YU (1) YU30299A (forum.php)
ZA (1) ZA9711734B (forum.php)

Families Citing this family (8)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
FR2787327B1 (fr) * 1998-12-21 2003-01-17 Aventis Pharma Sa Compositions contenant des inhibiteurs de farnesyle transferase
FR2796640A1 (fr) * 1999-07-22 2001-01-26 Aventis Pharma Sa Nouveaux inhibiteurs de farnesyle transferase, leur preparation, les compositions pharmaceutiques qui les contiennent et leur utilisation pour la preparation de medicaments
FR2796641B1 (fr) * 1999-07-22 2001-09-21 Aventis Pharma Sa Nouveau procede de preparation de composes benzoperhydroisoindole
FR2845994B1 (fr) * 2002-10-18 2006-05-19 Servier Lab Nouveaux derives de benzo[e][1,4]oxazino[3,2-g]isoindole substitues, leur procede de preparation et les compositions pharmaceutiques qui les contiennent
US20060106060A1 (en) * 2004-03-18 2006-05-18 The Brigham And Women's Hospital, Inc. Methods for the treatment of synucleinopathies (Lansbury)
TW202508595A (zh) 2023-05-04 2025-03-01 美商銳新醫藥公司 用於ras相關疾病或病症之組合療法
US20250154171A1 (en) 2023-10-12 2025-05-15 Revolution Medicines, Inc. Ras inhibitors
WO2025171296A1 (en) 2024-02-09 2025-08-14 Revolution Medicines, Inc. Ras inhibitors

Family Cites Families (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
NZ275691A (en) * 1993-11-05 1998-03-25 Warner Lambert Co Di and tripeptides and compositions thereof which inhibit farnesyl transferase
FR2736641B1 (fr) * 1995-07-10 1997-08-22 Rhone Poulenc Rorer Sa Nouveaux inhibiteurs de farnesyl transferase, leur preparation et les compositions pharmaceutiques qui les contiennent

Also Published As

Publication number Publication date
DE69711081T2 (de) 2002-08-01
NZ336042A (en) 2000-12-22
HUP0001747A3 (en) 2000-10-30
EP0948483A1 (fr) 1999-10-13
UY24832A1 (es) 2001-08-27
PL334345A1 (en) 2000-02-28
FR2757855A1 (fr) 1998-07-03
SK88399A3 (en) 2000-05-16
ID22922A (forum.php) 1999-12-16
CA2275943A1 (fr) 1998-07-09
NO993225L (no) 1999-08-24
ATE214367T1 (de) 2002-03-15
PE28199A1 (es) 1999-06-05
YU30299A (sh) 2002-03-18
DZ2389A1 (fr) 2002-12-28
ES2172033T3 (es) 2002-09-16
EA199900608A1 (ru) 2000-02-28
DE69711081D1 (de) 2002-04-18
WO1998029390A1 (fr) 1998-07-09
TR199901502T2 (xx) 1999-09-21
NO993225D0 (no) 1999-06-29
JP2001509147A (ja) 2001-07-10
EP0948483B1 (fr) 2002-03-13
AU741921B2 (en) 2001-12-13
AU5669498A (en) 1998-07-31
DK0948483T3 (da) 2002-07-01
IL130453A0 (en) 2000-06-01
CO4920252A1 (es) 2000-05-29
BR9714498A (pt) 2000-03-21
TNSN97214A1 (fr) 2005-03-15
AR008950A1 (es) 2000-02-23
MA26460A1 (fr) 2004-12-20
KR20000062391A (ko) 2000-10-25
HUP0001747A2 (hu) 2000-09-28
ZA9711734B (en) 1998-06-25
PT948483E (pt) 2002-08-30
FR2757855B1 (fr) 1999-01-29
EA002114B1 (ru) 2001-12-24

Similar Documents

Publication Publication Date Title
US6218406B1 (en) Farnesyl transferase inhibitors, their preparation, the pharmaceutical compositions which contain them and their use in the preparation of medicaments
US6124465A (en) Farnesyl transferase inhibitors, their preparation, the pharmaceutical compositions which contain them and their use in the preparation of medicaments
US7220769B2 (en) Azolylbenzamides and analogues and their use for treating osteoporosis
US7795250B2 (en) Indole derivatives as antiviral agents
CZ20014496A3 (cs) Indolové deriváty a jejich pouľití pro léčení osteoporózy
KR20050083918A (ko) Gsk-3베타 억제제로서의 피리다지논 유도체
JP2004536057A (ja) p38インヒビターとして使用する2,5−二置換ピリジン、ピリミジン、ピリダジンおよび1,2,4−トリアジンの誘導体
AU2008320718A1 (en) Indol-2-one derivatives disubstituted in the 3-position, preparation thereof and therapeutic use thereof
CZ233599A3 (cs) Inhibitory farnesyltransferázy, způsob jejich přípravy a farmaceutické prostředky, které je obsahují
DE69021855T2 (de) Quinazolinderivate und ihre Herstellung.
JPH06316564A (ja) モルフアナン類のo−アリールエーテル
US6291679B1 (en) Process for preparing benzoperhydroisoindole compounds
HUP0100785A2 (hu) Indolszármazékok, eljárás előállításukra és ezeket a vegyületeket tartalmazó gyógyászati készítmények
JP2000514078A (ja) 骨吸収阻害剤として有用なヘテロ芳香族ペンタジエン酸誘導体
JP4685307B2 (ja) ビトロネクチン受容体アンタゴニスト
JP2001527078A (ja) 新規なファルネシルトランスフェラーゼインヒビター、それらの製造、それらを含有する製薬学的組成物及び医薬品の製造のためのそれらの使用
WO2001036420A1 (fr) Derives d'aza-indolizine tricyclique ayant un effet inhibiteur sur spla¿2?
US4609733A (en) 3-keto-substituted-N-pyridylindoles
FR2772764A1 (fr) Nouveaux inhibiteurs de farnesyle transferase, leur preparation, les compositions pharmaceutiques qui les contiennent et leur utilisation pour la preparation de medicaments

Legal Events

Date Code Title Description
PD00 Pending as of 2000-06-30 in czech republic